Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2461 to 2475 of 8896 results

  1. Apremilast for treating juvenile psoriatic arthritis in people 5 to 17 years [TSID12089]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  2. Botulinum neurotoxin type E for treating moderate to severe glabellar lines [TSID12155]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  3. Tolebrutinib for treating primary progressive multiple sclerosis [ID6574]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  4. Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  5. Sulthiame for treating self-limiting epilepsy with centrotemporal spikes in children TSID 12106

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  6. Technologies to improve the detection of endometrial cancer

    Topic prioritisation

    Health technology evaluations
    Topic prioritisation

  7. Lonafarnib for treating progeria and progeroid laminopathies [ID3867]

    Topic prioritisation

    Highly specialised technologies guidance
    Topic prioritisation

  8. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  9. eXroid for internal haemorrhoids

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  10. Respirasense

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  11. Cyanoacrylate glue for hernia mesh fixation

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  12. Levodopa, carbidopa monohydrate and entacapone intestinal gel for treating the symptoms of advanced Parkinson's disease [ID4005]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  13. Natalizumab for treating highly active relapsing-remitting multiple sclerosis [ID4020]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  14. Nitisinone for treating alkaptonuria [ID2691]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  15. Remimazolam for general anaesthesia [ID3796]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation